Non-invasive Blood Glucose Monitoring Devices Market Estimated to Exceed US$ 74.5 Million Threshold by 2026 | CAGR: 35.0%: Coherent Market Insights
Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/1480
The global non-invasive blood glucose monitoring devices market, By Technology (Optical, Transdermal, Enzymatic, and Others), By Modality (Wearable, and Non-wearable), By End User (Hospitals, Home Care Settings, and Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was pegged at US$ 5.1 million in 2017, and is projected to witness a staggering 35.0% CAGR over the forecast period (2018-2026).
The surging global prevalence of diabetes and increasing R&D activities by various key players in the market to develop and launch innovative, cost-effective devices are among the pivotal factors expected to boost the growth of the global non-invasive blood glucose monitoring market.
Special Requirements?
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/1480
According to the International Diabetes Federation (IDF) Diabetes Atlas: 2017, the number of diabetic patients worldwide, aged between 20 years and 79 years, was valued at 425 million, which is estimated to increase by 48% in 2045. The key players are increasingly implementing inorganic growth strategies in order to gain a competitive edge in the global. For instance, in July 2018, Metamaterial Technologies Inc. acquired Medical Wireless Sensing Ltd. (MediWiSe). MediWiSe, for the record, has made significant advancements in non-invasive glucose monitoring and is working towards the development of a new product, called Glucowise.
Non-invasive glucose monitoring is known to offer painless, risk-free, low-cost, and frequent testing of glucose, and the tests majorly include the reverse iontophoresis method, optics-related method, metabolic heat confirmation method, and bio-impedance spectroscopy method among others. Owing to the complexity of human body composition and physiological processes, no single non-invasive method can achieve the reliable test results alone. Therefore, researchers are conducting studies on integration of multiple methods, which have become a major trend for research on non-invasive glucose monitoring.
Apply Promo Code “STAYHOME” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1480
Key Takeaways:
- Based on modality, the non-wearable segment is expected to account for a major market share by 2026. Increasing R&D activities by key players, combined with growing investor funding to back the research is expected to drive growth of the segment.
- The renowned players operating in the global non-invasive blood glucose monitoring devices market include DiaMonTech GmbH, Nemaura Medical Inc., Integrity Applications, Inc., CNOGA Medical Ltd., Breath Health, Inc., Metamaterial Technologies Inc., Opticology Inc., NovioSense BV, Quick LLC, and RSP Systems A/S.
- These players have been developing non-invasive devices, which integrate more than two detection methods. For instance, Glucotrack, a non-invasive intermittent glucose monitoring device for home-use, uses a combination of three technologies (ultrasonic, electromagnetic, and thermal) with a unique algorithm to weigh each measurement and calculate the weighted average of the three readings.
Have a Look at Related Research Insights:
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.
Editor Details
-
Company:
- CDN Newswire
